Qtron Investments LLC Boosts Stock Holdings in Cardinal Health, Inc. $CAH

Qtron Investments LLC grew its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 7.8% in the 1st quarter, Holdings Channel.com reports. The firm owned 7,913 shares of the company’s stock after buying an additional 572 shares during the period. Qtron Investments LLC’s holdings in Cardinal Health were worth $1,090,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Castlekeep Investment Advisors LLC acquired a new position in shares of Cardinal Health during the 4th quarter valued at about $141,963,000. JPMorgan Chase & Co. boosted its position in shares of Cardinal Health by 40.0% during the 1st quarter. JPMorgan Chase & Co. now owns 4,175,992 shares of the company’s stock valued at $575,327,000 after acquiring an additional 1,193,983 shares during the last quarter. GAMMA Investing LLC boosted its position in shares of Cardinal Health by 17,589.1% during the 1st quarter. GAMMA Investing LLC now owns 964,941 shares of the company’s stock valued at $132,940,000 after acquiring an additional 959,486 shares during the last quarter. Junto Capital Management LP acquired a new position in shares of Cardinal Health during the 4th quarter valued at about $92,811,000. Finally, Nuveen LLC acquired a new position in shares of Cardinal Health during the 1st quarter valued at about $106,065,000. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Cardinal Health Stock Performance

Shares of NYSE CAH opened at $149.49 on Monday. The firm has a market capitalization of $35.70 billion, a P/E ratio of 23.18, a PEG ratio of 1.26 and a beta of 0.67. Cardinal Health, Inc. has a one year low of $106.54 and a one year high of $168.44. The company’s fifty day moving average is $159.63 and its two-hundred day moving average is $144.72.

Cardinal Health (NYSE:CAH) last released its quarterly earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.03 by $0.05. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%. The business had revenue of $60.16 billion during the quarter, compared to the consensus estimate of $60.91 billion. During the same quarter in the previous year, the company posted $1.84 EPS. The business’s revenue was up .5% on a year-over-year basis. On average, sell-side analysts forecast that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be paid a dividend of $0.5107 per share. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.4%. Cardinal Health’s dividend payout ratio is currently 31.63%.

Analyst Ratings Changes

Several research analysts have recently weighed in on the stock. Leerink Partners lowered their price target on shares of Cardinal Health from $188.00 to $186.00 and set an “outperform” rating on the stock in a research report on Tuesday, August 12th. Wall Street Zen cut shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a research report on Saturday, August 2nd. Jefferies Financial Group set a $150.00 target price on shares of Cardinal Health in a research report on Tuesday, August 12th. Evercore ISI decreased their target price on shares of Cardinal Health from $200.00 to $190.00 and set an “outperform” rating on the stock in a research report on Wednesday, August 13th. Finally, Robert W. Baird upped their target price on shares of Cardinal Health from $197.00 to $203.00 and gave the company an “outperform” rating in a research report on Wednesday, August 13th. Three investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, Cardinal Health has a consensus rating of “Moderate Buy” and an average target price of $163.20.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.